Aglaia Oncology Funds

Brisbane, Australia
Firm Location:Brisbane, Australia • Netherlands
Investor Firms That Co-Invest with Aglaia Oncology Funds
ForbionBGV (BioGeneration Ventures)
Aglaia Oncology Funds Team
Photo of Mark Krul, Partner at Aglaia Oncology Funds
Mark Krul
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Mark
Photo of Marlies Laros, Aglaia Oncology Funds
Marlies Laros
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Marlies
Photo of Karl Rothweiler, Managing Partner at Aglaia Oncology Funds
Karl Rothweiler
Aglaia Oncology Funds·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Karl
Photo of Sanne Weijzen, Partner at Aglaia Oncology Funds
Sanne Weijzen
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Sanne